Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems

Separation and Purification Technology

Volumn 77, Issue 1, 2011, Pages 60-67

  Al Rifai, Jawad H ^a   Khabbaz, Hadi ^b   Schäfer, Andrea I ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endocrine disrupting compounds; Pharmaceuticals; Reverse osmosis (RO); Wastewater; Water recycling

Indexed keywords

ANALYTES; AUSTRALIA; BISPHENOL A; CARBAMAZEPINE; CONCENTRATION RANGES; ENDOCRINE DISRUPTING CHEMICALS; ENDOCRINE DISRUPTING COMPOUND; GEMFIBROZILS; HIGH QUALITY; INDUSTRIAL USERS; MICROPOLLUTANTS; ORDER OF MAGNITUDE; PHARMACEUTICALS; POLLUTANT CONCENTRATION; PRIMIDONE; QUEENSLAND; RECYCLED WATER; RECYCLING PROCESS; REMOVAL EFFICIENCIES; REVERSE OSMOSIS SYSTEMS; SALICYLIC ACIDS; SECONDARY TREATMENT; WASTEWATER TREATMENT PLANTS; WATER CONCENTRATIONS;

AMIDES; BIODEGRADATION; CONCENTRATION (PROCESS); DEWATERING; DRUG PRODUCTS; ENDOCRINOLOGY; INDUSTRIAL WATER TREATMENT; MICROFILTRATION; OSMOSIS MEMBRANES; PHENOLS; REMOVAL; REVERSE OSMOSIS; WASTEWATER; WASTEWATER RECLAMATION; WASTEWATER TREATMENT; WATER POLLUTION; WATER TREATMENT PLANTS;

WATER RECYCLING;

EID: 78751566705     PISSN: 13835866     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seppur.2010.11.020     Document Type: Article

References (55)

1. J. Fick, H. Söderström, R.H. Lindberg, C. Phan, M. Tysklind, and D.G.J. Larsson Contamination of surface, ground, and drinking water from pharmaceutical production Environmental Toxicology and Chemistry 28 2009 2522 2527
2. M.S. Díaz-Cruz, and D. Barceló Trace organic chemicals contamination in ground water recharge Chemosphere 72 2008 333 342
3. K.K. Barnes, D.W. Kolpin, E.T. Furlong, S.D. Zaugg, M.T. Meyer, and L.B. Barber A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States. I. Groundwater Science of the Total Environment 402 2008 192 200
4. M.J. Focazio, D.W. Kolpin, K.K. Barnes, E.T. Furlong, M.T. Meyer, S.D. Zaugg, L.B. Barber, and M.E. Thurman A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States. II. Untreated drinking water sources Science of the Total Environment 402 2008 201 216
5. S. Khan, Occurrence Behaviours Fate of Pharmaceutical Residues in Sewage Treatment, School of Civil and Environmental Engineering (PhD thesis), The University of New South Wales, Sydney, Australia (2002).
6. M.J. Gomez, M.J. Martinez Bueno, S. Lacorte, A.R. Fernandez-Alba, and A. Aguera Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast Chemosphere 66 2007 993 1002
7. N. Vieno, T. Tuhkanen, and L. Kronberg Seasonal variation in the occurrence of pharmaceuticals in the effluents from a sewage treatment plant and in the recipient water Environmental Science & Technology 39 2005 8220 8226
8. A.L. Spongberg, and J.D. Witter Pharmaceutical compounds in the wastewater process stream in Northwest Ohio Science of the Total Environment 397 2008 148 157
9. M. Clara, B. Strenn, O. Gans, E. Martinez, N. Kreuzinger, and H. Kroiss Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in membrane bioreactor and conventional wastewater treatment plant Water Research 39 2005 4797 4807
10. M. Jacob, C. Guigui, C. Cabassud, H. Darras, G. Lavison, and L. Moulin Performances of RO and NF processes for wastewater reuse: tertiary treatment after a conventional activated sludge or a membrane bioreactor Desalination 250 2010 833 839
11. A.M. Comerton, R.C. Andrews, D.M. Bagley, and C. Hao The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties Journal of Membrane Science 313 2008 323 335
12. J.E. Drewes, C. Bellona, M. Oedekoven, P. Xu, T.U. Kim, and G. Amy Rejection of wastewater-derived micropollutants in high-pressure membrane applications leading to indirect potable reuse Environmental Progress 24 2005 400 409
13. L.D. Nghiem, and A.I. Schäfer Trace contaminant removal with nanofiltration A. Schafer, A. Fane, T. Waite, Nanofiltration: Principle and Application 2005 Elsevier Science Ltd. 479 520
14. B. Van der Bruggen, C. Vandecasteele, T. Van Gestel, W. Doyen, and R. Leysen A review of pressure-driven membrane processes in wastewater treatment and drinking water production Environmental Progress 22 2003 46 56
15. H. Ozaki, and H. Li Rejection of organic compounds by ultra-low pressure reverse osmosis membrane Water Research 36 2002 123 130
16. M. Soltanieh, and S. Sahebdelfar Interaction effects in multicomponent separation by reverse osmosis Journal of Membrane Science 183 2001 15 27
17. K. Kimura, G. Amy, J. Drewes, and Y. Watanabe Adsorption of hydrophobic compounds onto NF/RO membranes: an artifact leading to overestimation of rejection Journal of Membrane Science 221 2003 89 101
18. P.K. Jjemba Excretion and ecotoxicity of pharmaceutical and personal care products in the environment Ecotoxicology and Environmental Safety 63 2006 113 130
19. T.A. Ternes, N. Herrmann, M. Bonerz, T. Knacker, H. Siegrist, and A. Joss A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge Water Research 38 2004 4075 4084
20. P. Xu, J.E. Drewes, C. Bellona, G. Amy, T.-U. Kim, M. Adam, and T. Heberer Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications Water Environment Research 77 2005 40 48 (Pubitemid 40283929)
21. S.A. Snyder, S. Adham, A.M. Redding, F.S. Cannon, J. DeCarolis, J. Oppenheimer, E.C. Wert, and Y. Yoon Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals Desalination 202 2007 156 181 (Pubitemid 44829082)
22. N. Lindqvist, T. Tuhkanen, and L. Kronberg Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters Water Research 39 2005 2219 2228
23. N. Nakada, H. Shinohara, A. Murata, K. Kiri, S. Managaki, N. Sato, and H. Takada Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant Water Research 41 2007 4373 4382
24. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernas, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G.L. Amidon Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Molecular Pharmaceutics 1 2004 85 96
25. L.D. Nghiem, and A.I. Schäfer Critical risk points of NF/RO membrane filtration processes in water recycling applications Desalination 187 2006 303 312
26. American Public Health Association (APHA) Standards Methods for the Examination of Water and Wastewater 21st ed. 2005 American Public Health Association (APHA) Washington, USA
27. X.A. Alvarez-Salgado, and A.E.J. Miller Simultaneous determination of dissolved organic carbon and total dissolved nitrogen in seawater by high temperature catalytic oxidation: conditions for precise shipboard measurements Marine Chemistry 62 1998 325 333
28. J.H. Al-Rifai, C.L. Gabelish, and A.I. Schafer Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia Chemosphere 69 2007 803 815
29. J.H. Ryther, and W.M. Dunstan Nitrogen, phosphorus, and eutrophication in the coastal marine environment Science 171 1971 1008 1013
30. S.J. Khan, T. Wintgens, P. Sherman, J. Zaricky, and A. Schäfer A performance comparison of individual and combined treatment modules for water recycling Environmental Progress 24 2005 383 391
31. Department of Health Aging Australian Statistics on Medicines Commonwealth of Australia 2003 2005
32. M. Cleuvers Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid Ecotoxicology and Environmental Safety 59 2004 309 315
33. T. Pham, and S. Proulx PCBs and PAHs in the Montreal urban community (Quebec, Canada) wastewater treatment plant and in the effluent plume in the St Lawrence River Water Research 31 1997 1887 1896
34. T.A. Ternes Occurrence of drugs in German sewage treatment plants and rivers Water Research 32 1998 3245 3260
35. M. Blanchard, M. Teil, D. Ollivon, L. Legenti, and M. Chevreuil Polycyclic aromatic hydrocarbons and polychlorobiphenyls in wastewater and sewage sludge from Paris area (France) Environmental Research 95 2004 184 197
36. N. Nakada, T. Tanishima, H. Shinohara, K. Kiri, and H. Takada Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment Water Research 40 2006 3297 3303
37. M. Stumpf, T.A. Ternes, R.-D. Wilken, R. Silvana Vianna, and W. Baumann Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil Science of The Total Environment 225 1999 135 141
38. D. Bendz, N.A. Paxeus, T.R. Ginn, and F.J. Loge Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden Journal of Hazardous Material 122 2005 195 204
39. C.M. Coetsier, S. Spinelli, L. Lin, B. Roig, and E. Touraud Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs? Environment International 35 2009 787 792
40. S. Castiglioni, R. Bagnati, R. Fanelli, F. Pomati, D. Calamari, and E. Zuccato Removal of pharmaceuticals in sewage treatment plants in Italy Environmental Science & Technology 40 2005 357 363
41. C.A. Staples, P.B. Dome, G.M. Klecka, S.T. Oblock, and L.R. Harris A review of the environmental fate, effects, and exposures of bisphenol A Chemosphere 36 1998 2149 2173
42. R Bergeron, T. Thompson, L. Leonard, L. Pluta, and K. Gaido Estrogenicity of bisphenol A in a human endometrial carcinoma cell line Molecular and Cellular Endocrinology 150 1999 179 187
43. M. Sekela, R. Brewer, G. Moyle, and T. Tuominen Occurrence of an environmental estrogen (4-nonylphenol) in sewage treatment plant effluent and the aquatic receiving environment Water Science and Technology 39 1999 2170 2220
44. J.L. Santos, I. Aparicio, and E. Alonso Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain) Environment International 33 2007 596 601
45. X.F. Zhou, C.M. Dai, Y.L. Zhang, R.Y. Surampalli, T.C. Zhang, A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China, Environmental Monitoring and Assessment (2010), doi:10.1007/s10661-010-1369-8.
46. M. Clara, S. Scharf, C. Scheffknecht, and O. Gans Occurrence of selected surfactants in untreated and treated sewage Water Research 41 2007 4339 4348
47. H.B. Lee, T.E. Peart, J. Chan, and G. Gris Occurrence of endocrine-disrupting chemicals in sewage and sludge samples in Toronto, Canada Water Quality Research Journal of Canada 39 2004 57 63
48. O.A.H. Jones, N. Voulvoulis, and J.N. Lester Human pharmaceuticals in wastewater treatment processes Critical Reviews in Environmental Science and Technology 35 2005 401 427
49. K. Kimura, S. Toshima, G. Amy, and Y. Watanabe Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes Journal of Membrane Science 245 2004 71 78
50. A. Simon, L.D. Nghiem, P. Le-Clech, S.J. Khan, and J.E. Drewes Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes Journal of Membrane Science 340 2009 16 25
51. D. Bing-zhi, W. Lin, and G. Nai-yun The removal of bisphenol A by ultrafiltration Desalination 221 2008 312 317
52. Y. Zhang, C. Causserand, P. Aimar, and J.P. Cravedi Removal of bisphenol A by a nanofiltration membrane in view of drinking water production Water Research 40 2006 3793 3799
53. K.O. Agenson, J.-I. Oh, and T. Urase Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: controlling parameters of process Journal of Membrane Science 225 2003 91 103
54. P.H. Roberts, and K.V. Thomas The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment Science of the Total Environment 356 2006 143 153
55. E.M. Snyder, R.C. Pleus, and S.A. Snyder Pharmaceuticals EDCS in the US water industry-an update Journal of the American Water Works Association 97 2005 32 36